RPRX and ZYME Related Headlines

Go Back

Mar 2, 2026 06:10AM Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

Mar 2, 2026 06:01AM Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma

Mar 2, 2026 06:01AM Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

RPRX and ZYME Related Press Releases

Go Back

Mar 2, 2026 06:10AM Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing

Mar 2, 2026 06:01AM Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing

RPRX and ZYME Related SEC Filings

Go Back